Gastroduodenal Committee Terms of Reference

  • To support training, education, research and guidelines of Gastroduodenal studies within the BSG
  • To work alongside different external bodies to promote the expanding role of Gastroduodenal studies In the UK
  • To represent the interests and issues of the BSG members specialised in Gastroduodenal
  • To manage the future direction of the Gastroduodenal committee in accordance with shifts In the NHS
  • To develop professional collaborations nationally and internationally with the formal approval of the Executive.
  • To support the recruitment and retention of members in the specialty of Gastroenterology.
  • To hold a monothematic meeting every 3 years to promote the work of the specialty group to the broader community.
  • The scope of the GDS covers the education, training and clinical practice of the whole spectrum of benign and neoplastic gastroduodenal diseases, including functional diseases that have manifestations in the upper GI tract.
  • The work of the GDS committee encompasses common and important disorders including peptic ulcer disease, gastric neoplasia and pre-neoplasia, acute and chronic bleeding from the upper GI tract, Iron-deficiency and B12-deficieincy anaemia, gastritis, benign gastric mass lesions and the spectrum of functional upper GI disorders. This list is not exclusive and the GDS committee, on behalf of the section, provides leadership related to the clinical and public health aspects of all gastroduodenal diseases.
  • The GDS committee will liaise with other BSG sections as appropriate, principally with, but not limited to, the oesophageal, neurogastroenterology & motility, endoscopy, small bowel and trainees sections to promote and develop clinical practice, education and research initiatives.
  • The work of the GDS committee includes collaborative work with non-BSG stakeholders as appropriate for the development of clinical practice, research and education.
High Level Strategic Objectives
  • Maintain a high and visible profile both within the BSG and with outside agencies (e.g. Royal College of Physicians, NIHR) as a resource for advice and support related to gastroduodenal disorders
  • Completion and publication of the updated guidelines on Iron-deficiency anaemia
  • Contribute in a tangible and measurable way to local, national and international research programmes
Membership (eligibility criteria)
  • The Section Committee/CRG must have a minimum of 4 members and a maximum of 12, one of which must be a Trainee
  • The Committee will be responsible for ensuring that the section meets its strategic objectives
  • The appointment term for committee membership is 3 years
  • The Chair and Secretary will be elected from the membership of the Committee and will each serve 3 years
  • The Chair is able to co-opt members to join the Committee with the approval of the Section
  • Co-opted members will be ‘task and time limited’ to respect the democratic election process within the Society. Co-opted members should not be granted ongoing roles within the Committee after the timebound task for which they have been co-opted.  A record of co-opted members should be agreed by the Committee and members should be stood down once their task is completed
The meeting will be quorate if, as a minimum, the following members are present:
Chair or Secretary
At least 4 Section representatives 

Register of members